InsiderSource
EIKN

Eikon Therapeutics, Inc.

SEC CIK 1861123
$8.52 −43.2% · 90 days
90-day buys
$0
0 open-market
90-day sells
$0
0 open-market
Net insider flow
+$0
Net buying
Filings shown
37
Most recent

At a glance

Insiders at EIKN have made no open-market trades in the last 90 days — the activity below is grants, option exercises, and other routine filings.

Largest recent trade: Column Group Iv Gp, Lp, EIKN's 10% owner, spent $25.87M of their own money on 1.44M shares at $18, growing their stake 50%.

Most active filer: Foresite Capital Management Iv, Llc, with 15 transactions among the recent filings shown.

Insider transaction history

Form 4 filings for EIKN, newest first
View on SEC EDGAR ↗
EIKN
Eikon Therapeutics, Inc.
Buy Column Group IV GP, LP · 10% Owner · Open-market purchase · filed Feb 9, 2026 ΔOwn +50%

Column Group Iv Gp, Lp, EIKN's 10% owner, spent $25.87M of their own money on 1.44M shares at $18, growing their stake 50%.

+$25.87M
1.44M sh @ $18
EIKN
Eikon Therapeutics, Inc.
Buy Column Group IV GP, LP · 10% Owner · Open-market purchase · filed Feb 9, 2026 ΔOwn +50%

Column Group Iv Gp, Lp, EIKN's 10% owner, spent $892K of their own money on 49,556 shares at $18, growing their stake 50%.

+$892K
49,556 sh @ $18
EIKN
Eikon Therapeutics, Inc.
Buy Column Group IV GP, LP · 10% Owner · Open-market purchase · filed Feb 9, 2026 ΔOwn +92%

Column Group Iv Gp, Lp, EIKN's 10% owner, spent $11.36M of their own money on 630,881 shares at $18, growing their stake 92%.

+$11.36M
630,881 sh @ $18
EIKN
Eikon Therapeutics, Inc.
Buy Foresite Capital Management IV, LLC · 10% Owner · Open-market purchase · filed Feb 6, 2026 ΔOwn +4.4%

Foresite Capital Management Iv, Llc, EIKN's 10% owner, spent $1,000K of their own money on 55,555 shares at $18, growing their stake 4%.

+$1,000K
55,555 sh @ $18
EIKN
Eikon Therapeutics, Inc.
Buy FRAZIER KENNETH C · Director · Open-market purchase · filed Feb 6, 2026 ΔOwn NEW

Frazier Kenneth C, EIKN's Director, spent $2M of their own money on 111,111 shares at $18, opening a brand-new position.

+$2M
111,111 sh @ $18
EIKN
Eikon Therapeutics, Inc.
Buy Wolfe Josh · Director, 10% Owner · Open-market purchase · filed Feb 6, 2026 ΔOwn NEW

Wolfe Josh, EIKN's 10% owner, spent $2.5M of their own money on 138,888 shares at $18, opening a brand-new position.

+$2.5M
138,888 sh @ $18
EIKN
Eikon Therapeutics, Inc.
Buy Wolfe Josh · Director, 10% Owner · Open-market purchase · filed Feb 6, 2026 ΔOwn NEW

Wolfe Josh, EIKN's 10% owner, spent $2.5M of their own money on 138,888 shares at $18, opening a brand-new position.

+$2.5M
138,888 sh @ $18
EIKN
Eikon Therapeutics, Inc.
Buy Lux Venture Partners V, LLC · 10% Owner · Open-market purchase · filed Feb 6, 2026 ΔOwn NEW

Lux Venture Partners V, Llc, EIKN's 10% owner, spent $2.5M of their own money on 138,888 shares at $18, opening a brand-new position.

+$2.5M
138,888 sh @ $18
EIKN
Eikon Therapeutics, Inc.
Buy Lux Venture Partners V, LLC · 10% Owner · Open-market purchase · filed Feb 6, 2026 ΔOwn NEW

Lux Venture Partners V, Llc, EIKN's 10% owner, spent $2.5M of their own money on 138,888 shares at $18, opening a brand-new position.

+$2.5M
138,888 sh @ $18

About EIKN insider activity

This page tracks every recent Form 4 filed for Eikon Therapeutics, Inc. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is EIKN insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for Eikon Therapeutics, Inc. usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.